NON-SMALL CELL LUNG CANCER WITH STK11/LKB1 MUTATION

Clinical trials for NON-SMALL CELL LUNG CANCER WITH STK11/LKB1 MUTATION explained in plain language.

Never miss a new study

Get alerted when new NON-SMALL CELL LUNG CANCER WITH STK11/LKB1 MUTATION trials appear

Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER WITH STK11/LKB1 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New hope for Tough-to-Treat lung cancer? drug trial targets specific mutation

Disease control Completed

This study tested whether a drug called daratumumab, given as an injection under the skin, could help control advanced lung cancer that has a specific genetic change (STK11 mutation) and has stopped responding to standard treatments. Eight patients who had already tried chemother…

Matched conditions: NON-SMALL CELL LUNG CANCER WITH STK11/LKB1 MUTATION

Phase: PHASE2 • Sponsor: NYU Langone Health • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

NON-SMALL CELL LUNG CANCER WITH STK11/LKB1 MUTATION

Get alerted when new NON-SMALL CELL LUNG CANCER WITH STK11/LKB1 MUTATION trials appear

New hope for Tough-to-Treat lung cancer? drug trial targets specific mutation